Efficacy and safety of transcutaneous auricular vagus nerve stimulation for frequent premature ventricular complexes: rationale and design of the TASC-V trial.
Yu Liu, Xinyao Wei, Lixin Wang...
https://pubmed.ncbi.nlm.nih.gov/39075454/Actively Recruiting
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2025-07-20
90
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the safety and effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation TAVNS for adults with frequent premature ventricular complexes FPVCs. This randomized controlled trial will compare TAVNS plus usual medical care to a sham-TAVNS plus usual care to see if TAVNS can reduce the number of premature ventricular complexes. The study will include 90 participants aged 18 to 75 and is sponsored by Guanganmen Hospital of China Academy of Chinese Medical Sciences. Participants will be randomly assigned to receive either the TAVNS treatment or a sham version without electrical current, both targeting specific ear acupuncture points related to the vagus nerve. Treatments will be delivered using a Huato type SDZ-V stimulator for 6 weeks alongside their usual care for PVCs. After the 6-week treatment, participants will be followed for an additional 12 weeks to monitor ongoing effects and safety. During the study, participants will have their heart activity monitored to measure the reduction in premature ventricular complexes and other heart rhythm changes at 6 and 18 weeks. Symptom changes related to palpitation, chest tightness, dizziness, and insomnia will be assessed, along with anxiety and depression scores. Safety will be continuously observed, and subgroup analyses will consider age, gender, and severity of PVCs. The total study duration for each participant will be 18 weeks including follow-up.
CONDITIONS
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
J
Jiani Wu
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor
China Association for Science and Technology
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive Transcutaneous Auricular Vagus Nerve Stimulation (TAVNS) or Sham-TAVNS on specific auricular acupuncture points, along with usual care, for frequent premature ventricular complexes.
Weekly visits for up to 6 weeks
Duration - Up to 12 weeks after treatment
Participants are monitored for changes in premature ventricular contractions and symptoms up to 18 weeks after starting treatment.
Visits at week 6 and week 18
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yu Liu, Xinyao Wei, Lixin Wang...
https://pubmed.ncbi.nlm.nih.gov/39075454/Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor
China Association for Science and Technology
Collaborating Sponsor